Microcalorimetric studies on the complex formation between cellobiohydrolase I (CBH I) from Trichoderma reesei and the (R)- and (S)-enantiomers of the β-receptor blocking agent Alprenolol (cas 13655-52-2)
-
Add time:09/26/2019 Source:sciencedirect.com
The thermodynamic quantities for the complex formation between the enantiomers of the β-blocking drug alprenolol and cellobiohydrolase I (CBH I), that earlier has been used as a chiral selector for aminoalcohols, revealed positive ΔH0 — values in all cases implying an entropy driven process. Association constants (Ka) for cellulase and the (R)- and (S)-enantiomers of alprenolol were determined by isothermal titration microcalorimetry and the inhibition constants (Ki) by enzyme inhibition experiments. Both inhibition experiments and microcalorimetry revealed that the affinity between the enantiomers of alprenolol and CBH I was higher in sodium phosphate buffer than in potassium phosphate buffer. This result was in agreement with previously reported liquid chromatographic separations of enantiomers using a chiral stationary phase based on CBH I immobilized to silica particles. The best fit of the isothermal titration data corresponded to a 1:1 binding isotherm.
We also recommend Trading Suppliers and Manufacturers of Alprenolol (cas 13655-52-2). Pls Click Website Link as below: cas 13655-52-2 suppliers
Prev:Gel formulations containing catanionic vesicles composed of Alprenolol (cas 13655-52-2) and SDS: Effects of drug release and skin penetration on aggregate structure
Next:Combined pharmacokinetic and pharmacodynamic studies on Alprenolol (cas 13655-52-2) and 4-hydroxy-Alprenolol (cas 13655-52-2) in man) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Combined pharmacokinetic and pharmacodynamic studies on Alprenolol (cas 13655-52-2) and 4-hydroxy-Alprenolol (cas 13655-52-2) in man09/27/2019
- Gel formulations containing catanionic vesicles composed of Alprenolol (cas 13655-52-2) and SDS: Effects of drug release and skin penetration on aggregate structure09/25/2019
- Regular paperAnalysis of the vasodilator action of Alprenolol (cas 13655-52-2)09/24/2019
- Nasal absorption of Alprenolol (cas 13655-52-2) and metoprolol09/10/2019
- Enantioselective determination of Alprenolol (cas 13655-52-2) in human plasma by liquid chromatography with tandem mass spectrometry using cellobiohydrolase chiral stationary phases09/09/2019
- Electrophoretic behavior of Alprenolol (cas 13655-52-2) in mixed solvent electrolyte systems09/08/2019
- Enantioselective biodegradation of pharmaceuticals, Alprenolol (cas 13655-52-2) and propranolol, by an activated sludge inoculum09/07/2019
- Labeling of Alprenolol (cas 13655-52-2) with fluorescent aryl iodide as a reagent based on Mizoroki–Heck coupling reaction09/06/2019
- Quantification of Alprenolol (cas 13655-52-2) and propranolol in human plasma using a two-dimensional liquid chromatography (2D-LC)09/05/2019


